About 40% of the US revenues of Sun Pharmaceutical Industries, India's most valuable pharmaceutical company, is linked to its Halol site. For FY17, Sun Pharma had revenues of Rs 30,264 crore, of which Rs 13,300 crore came from the US (including the benefits of exclusivity-period opportunities of the ...
Read more: Is Sun Pharma's Halol site close to a rebound?